Share Price and Basic Stock Data
Last Updated: November 28, 2025, 7:48 am
| PEG Ratio | 2.01 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
CARE Ratings Ltd operates in the rating services industry, with its current share price at ₹1,537 and a market capitalization of ₹4,613 Cr. The company reported a total sales figure of ₹279 Cr for the fiscal year ending March 2023, which is an increase from ₹248 Cr in the previous fiscal year. The revenue trajectory indicates a promising upward trend, with sales projected to rise to ₹332 Cr in March 2024 and further to ₹402 Cr by March 2025. Quarterly sales have shown variability, with the most recent quarter (September 2023) recording sales of ₹96 Cr. This marks a significant recovery from ₹66 Cr in June 2023, thus reflecting the company’s ability to adapt to changing market conditions. The operating profit margin (OPM) stood at 39% for the trailing twelve months, suggesting a robust operational efficiency compared to industry norms.
Profitability and Efficiency Metrics
CARE Ratings Ltd has demonstrated strong profitability metrics with a net profit of ₹155 Cr reported for the fiscal year ending March 2023. The company’s return on equity (ROE) stood at 18% while return on capital employed (ROCE) was recorded at 24.6%, indicating effective utilization of shareholder equity and capital. The interest coverage ratio (ICR) was exceptionally high at 97.76x, showcasing the company’s ability to comfortably meet its interest obligations. The operating profit for the last fiscal year was ₹99 Cr, with a corresponding OPM of 36%. This is indicative of the company’s strong operational control. The net profit margin also reflects strength, recorded at 30.63% for March 2023, which is above the industry average. Overall, these metrics position CARE Ratings favorably within the rating services sector.
Balance Sheet Strength and Financial Ratios
The balance sheet of CARE Ratings Ltd reflects solid financial health, with total assets amounting to ₹958 Cr as of March 2025. The company reported reserves of ₹776 Cr and minimal borrowings of ₹24 Cr, emphasizing its low debt levels and strong equity position. The current ratio stood at a healthy 7.08, indicating a strong ability to cover short-term liabilities. Additionally, the price-to-book value (P/BV) ratio was noted at 4.09x, which suggests that the stock is trading at a premium compared to its book value, often a sign of investor confidence. The company’s dividend payout ratio for the fiscal year ending March 2025 was reported at 39.20%, indicating a balanced approach to returning capital to shareholders while maintaining sufficient reinvestment for growth. This financial stability is critical for sustaining its operations and strategic initiatives.
Shareholding Pattern and Investor Confidence
The shareholding pattern of CARE Ratings Ltd indicates a diverse investor base, with foreign institutional investors (FIIs) holding 23.61% and domestic institutional investors (DIIs) accounting for 31.60% as of March 2025. The public holds a significant 44.79% stake in the company, with a total of 56,931 shareholders. The gradual increase in FIIs from 17.99% in December 2022 to 23.61% in March 2025 signals growing confidence among international investors. Additionally, DIIs increased their stake from 25.06% in December 2022 to 31.60% in March 2025, suggesting robust institutional support. However, the decline in public shareholding from 56.94% in December 2022 to 44.79% in March 2025 could indicate a shift in retail investor sentiment, which warrants monitoring. Overall, the current investor confidence appears strong, bolstered by the company’s financial performance.
Outlook, Risks, and Final Insight
Looking ahead, CARE Ratings Ltd faces a mix of opportunities and risks. The increasing trend in revenue and profitability metrics suggests a positive outlook for the upcoming fiscal years. However, potential risks include regulatory changes in the rating industry and economic fluctuations that could impact client demand for ratings. The company’s low debt levels and strong cash flow generation position it well to navigate challenges. Furthermore, the high interest coverage ratio signifies resilience against financial pressures. If the company continues to innovate and expand its service offerings, it may capitalize on growing market needs. Conversely, any significant downturn in the economic environment or a reduction in demand for credit ratings could adversely affect performance. Thus, maintaining operational efficiency and adapting to market dynamics will be crucial for CARE Ratings’ sustained growth.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of CARE Ratings Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| ICRA Ltd | 5,965 Cr. | 6,188 | 7,135/5,015 | 31.7 | 1,127 | 0.97 % | 23.1 % | 16.8 % | 10.0 |
| CARE Ratings Ltd | 4,613 Cr. | 1,537 | 1,965/1,052 | 30.2 | 288 | 1.17 % | 24.6 % | 18.0 % | 10.0 |
| Industry Average | 5,289.00 Cr | 3,862.50 | 30.95 | 707.50 | 1.07% | 23.85% | 17.40% | 10.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 55 | 85 | 62 | 78 | 66 | 96 | 79 | 90 | 79 | 117 | 96 | 110 | 94 |
| Expenses | 38 | 43 | 48 | 50 | 49 | 55 | 55 | 61 | 57 | 62 | 66 | 62 | 66 |
| Operating Profit | 16 | 42 | 14 | 27 | 18 | 42 | 23 | 29 | 22 | 56 | 30 | 47 | 28 |
| OPM % | 30% | 50% | 22% | 35% | 27% | 43% | 30% | 32% | 28% | 47% | 32% | 43% | 30% |
| Other Income | 8 | 8 | 12 | 10 | 12 | 11 | 14 | 10 | 12 | 12 | 12 | 15 | 14 |
| Interest | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| Depreciation | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Profit before tax | 21 | 48 | 23 | 34 | 26 | 50 | 34 | 36 | 30 | 64 | 39 | 59 | 37 |
| Tax % | 33% | 27% | 28% | 41% | 31% | 29% | 30% | 32% | 30% | 27% | 27% | 26% | 29% |
| Net Profit | 14 | 35 | 16 | 20 | 18 | 36 | 24 | 25 | 21 | 47 | 28 | 43 | 26 |
| EPS in Rs | 4.61 | 11.57 | 5.38 | 6.60 | 5.99 | 11.81 | 7.88 | 8.07 | 6.94 | 15.41 | 9.29 | 14.24 | 8.61 |
Last Updated: August 20, 2025, 12:25 pm
Below is a detailed analysis of the quarterly data for CARE Ratings Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 94.00 Cr.. The value appears to be declining and may need further review. It has decreased from 110.00 Cr. (Mar 2025) to 94.00 Cr., marking a decrease of 16.00 Cr..
- For Expenses, as of Jun 2025, the value is 66.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 62.00 Cr. (Mar 2025) to 66.00 Cr., marking an increase of 4.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 28.00 Cr.. The value appears to be declining and may need further review. It has decreased from 47.00 Cr. (Mar 2025) to 28.00 Cr., marking a decrease of 19.00 Cr..
- For OPM %, as of Jun 2025, the value is 30.00%. The value appears to be declining and may need further review. It has decreased from 43.00% (Mar 2025) to 30.00%, marking a decrease of 13.00%.
- For Other Income, as of Jun 2025, the value is 14.00 Cr.. The value appears to be declining and may need further review. It has decreased from 15.00 Cr. (Mar 2025) to 14.00 Cr., marking a decrease of 1.00 Cr..
- For Interest, as of Jun 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 37.00 Cr.. The value appears to be declining and may need further review. It has decreased from 59.00 Cr. (Mar 2025) to 37.00 Cr., marking a decrease of 22.00 Cr..
- For Tax %, as of Jun 2025, the value is 29.00%. The value appears to be increasing, which may not be favorable. It has increased from 26.00% (Mar 2025) to 29.00%, marking an increase of 3.00%.
- For Net Profit, as of Jun 2025, the value is 26.00 Cr.. The value appears to be declining and may need further review. It has decreased from 43.00 Cr. (Mar 2025) to 26.00 Cr., marking a decrease of 17.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 8.61. The value appears to be declining and may need further review. It has decreased from 14.24 (Mar 2025) to 8.61, marking a decrease of 5.63.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 5:35 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 236 | 261 | 279 | 287 | 333 | 319 | 244 | 248 | 248 | 279 | 332 | 402 | 436 |
| Expenses | 88 | 101 | 105 | 105 | 122 | 144 | 162 | 153 | 168 | 180 | 220 | 247 | 262 |
| Operating Profit | 148 | 160 | 174 | 182 | 211 | 175 | 81 | 96 | 80 | 99 | 112 | 155 | 174 |
| OPM % | 63% | 61% | 62% | 63% | 63% | 55% | 33% | 39% | 32% | 36% | 34% | 39% | 40% |
| Other Income | 36 | 44 | 9 | 34 | 25 | 30 | 31 | 31 | 27 | 38 | 47 | 51 | 53 |
| Interest | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 2 | 2 | 2 |
| Depreciation | 3 | 5 | 4 | 3 | 3 | 3 | 8 | 8 | 8 | 11 | 10 | 12 | 13 |
| Profit before tax | 181 | 197 | 178 | 212 | 233 | 202 | 104 | 119 | 99 | 126 | 147 | 192 | 212 |
| Tax % | 28% | 30% | 33% | 31% | 30% | 32% | 20% | 23% | 22% | 32% | 30% | 27% | |
| Net Profit | 130 | 138 | 120 | 148 | 162 | 138 | 83 | 91 | 77 | 85 | 103 | 140 | 155 |
| EPS in Rs | 44.63 | 47.53 | 40.68 | 50.13 | 55.13 | 46.66 | 27.96 | 30.39 | 25.34 | 28.12 | 33.67 | 45.85 | 51.03 |
| Dividend Payout % | 63% | 166% | 69% | 56% | 100% | 64% | 70% | 56% | 67% | 89% | 53% | 39% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 6.15% | -13.04% | 23.33% | 9.46% | -14.81% | -39.86% | 9.64% | -15.38% | 10.39% | 21.18% | 35.92% |
| Change in YoY Net Profit Growth (%) | 0.00% | -19.20% | 36.38% | -13.87% | -24.27% | -25.04% | 49.49% | -25.02% | 25.77% | 10.79% | 14.75% |
CARE Ratings Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 11% |
| 3 Years: | 18% |
| TTM: | 21% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 11% |
| 3 Years: | 22% |
| TTM: | 38% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 30% |
| 3 Years: | 44% |
| 1 Year: | 55% |
| Return on Equity | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 15% |
| 3 Years: | 15% |
| Last Year: | 18% |
Last Updated: September 5, 2025, 1:35 am
Balance Sheet
Last Updated: July 25, 2025, 3:26 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 30 | 30 | 30 | 30 |
| Reserves | 456 | 330 | 379 | 491 | 567 | 521 | 504 | 559 | 618 | 643 | 687 | 776 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 9 | 17 | 20 | 24 |
| Other Liabilities | 96 | 87 | 94 | 64 | 61 | 64 | 85 | 74 | 69 | 80 | 105 | 128 |
| Total Liabilities | 581 | 446 | 502 | 584 | 658 | 614 | 618 | 671 | 725 | 770 | 842 | 958 |
| Fixed Assets | 59 | 65 | 64 | 61 | 60 | 83 | 93 | 85 | 96 | 107 | 109 | 119 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 3 | 8 | 4 | 6 | 3 |
| Investments | 459 | 335 | 381 | 466 | 518 | 439 | 339 | 240 | 44 | 44 | 44 | 134 |
| Other Assets | 63 | 46 | 58 | 57 | 79 | 93 | 185 | 343 | 577 | 614 | 683 | 702 |
| Total Assets | 581 | 446 | 502 | 584 | 658 | 614 | 618 | 671 | 725 | 770 | 842 | 958 |
Below is a detailed analysis of the balance sheet data for CARE Ratings Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 30.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 30.00 Cr..
- For Reserves, as of Mar 2025, the value is 776.00 Cr.. The value appears strong and on an upward trend. It has increased from 687.00 Cr. (Mar 2024) to 776.00 Cr., marking an increase of 89.00 Cr..
- For Borrowings, as of Mar 2025, the value is 24.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 20.00 Cr. (Mar 2024) to 24.00 Cr., marking an increase of 4.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 128.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 105.00 Cr. (Mar 2024) to 128.00 Cr., marking an increase of 23.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 958.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 842.00 Cr. (Mar 2024) to 958.00 Cr., marking an increase of 116.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 119.00 Cr.. The value appears strong and on an upward trend. It has increased from 109.00 Cr. (Mar 2024) to 119.00 Cr., marking an increase of 10.00 Cr..
- For CWIP, as of Mar 2025, the value is 3.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6.00 Cr. (Mar 2024) to 3.00 Cr., marking a decrease of 3.00 Cr..
- For Investments, as of Mar 2025, the value is 134.00 Cr.. The value appears strong and on an upward trend. It has increased from 44.00 Cr. (Mar 2024) to 134.00 Cr., marking an increase of 90.00 Cr..
- For Other Assets, as of Mar 2025, the value is 702.00 Cr.. The value appears strong and on an upward trend. It has increased from 683.00 Cr. (Mar 2024) to 702.00 Cr., marking an increase of 19.00 Cr..
- For Total Assets, as of Mar 2025, the value is 958.00 Cr.. The value appears strong and on an upward trend. It has increased from 842.00 Cr. (Mar 2024) to 958.00 Cr., marking an increase of 116.00 Cr..
Notably, the Reserves (776.00 Cr.) exceed the Borrowings (24.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 148.00 | 160.00 | 174.00 | 182.00 | 211.00 | 175.00 | 81.00 | 89.00 | 71.00 | 82.00 | 92.00 | 131.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 23 | 22 | 31 | 32 | 43 | 54 | 61 | 31 | 25 | 27 | 25 | 29 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 23 | 22 | 31 | 32 | 43 | 54 | 61 | 31 | 25 | 27 | 25 | 29 |
| Working Capital Days | -100 | -82 | -65 | -10 | -1 | 13 | 14 | -3 | 635 | 638 | 591 | 451 |
| ROCE % | 36% | 39% | 46% | 44% | 41% | 35% | 19% | 21% | 16% | 19% | 21% | 25% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Quant Active Fund | 117,502 | 0.1 | 11.64 | 117,502 | 2025-04-22 15:56:59 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 45.89 | 33.77 | 28.17 | 25.45 | 30.38 |
| Diluted EPS (Rs.) | 45.69 | 33.77 | 28.17 | 25.45 | 30.38 |
| Cash EPS (Rs.) | 50.69 | 37.87 | 32.32 | 28.51 | 33.52 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 269.37 | 240.23 | 228.63 | 220.20 | 201.29 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 269.37 | 240.23 | 228.63 | 220.20 | 201.29 |
| Revenue From Operations / Share (Rs.) | 134.41 | 111.11 | 93.94 | 83.53 | 84.33 |
| PBDIT / Share (Rs.) | 68.85 | 53.20 | 46.22 | 36.02 | 43.13 |
| PBIT / Share (Rs.) | 64.94 | 49.69 | 42.67 | 33.42 | 40.48 |
| PBT / Share (Rs.) | 64.23 | 49.12 | 42.34 | 33.27 | 40.27 |
| Net Profit / Share (Rs.) | 46.77 | 34.36 | 28.77 | 25.91 | 30.88 |
| NP After MI And SOA / Share (Rs.) | 45.85 | 33.67 | 28.12 | 25.33 | 30.38 |
| PBDIT Margin (%) | 51.22 | 47.88 | 49.20 | 43.12 | 51.14 |
| PBIT Margin (%) | 48.31 | 44.72 | 45.43 | 40.01 | 48.00 |
| PBT Margin (%) | 47.78 | 44.20 | 45.07 | 39.82 | 47.75 |
| Net Profit Margin (%) | 34.79 | 30.92 | 30.63 | 31.02 | 36.61 |
| NP After MI And SOA Margin (%) | 34.11 | 30.30 | 29.93 | 30.33 | 36.03 |
| Return on Networth / Equity (%) | 17.02 | 14.01 | 12.42 | 11.59 | 15.20 |
| Return on Capital Employeed (%) | 22.60 | 19.43 | 17.80 | 14.65 | 19.27 |
| Return On Assets (%) | 14.32 | 11.94 | 10.83 | 10.32 | 13.32 |
| Asset Turnover Ratio (%) | 0.44 | 0.41 | 0.33 | 0.31 | 0.34 |
| Current Ratio (X) | 7.08 | 8.57 | 10.19 | 11.01 | 10.34 |
| Quick Ratio (X) | 7.08 | 8.57 | 10.19 | 11.01 | 10.34 |
| Dividend Payout Ratio (NP) (%) | 39.20 | 65.09 | 71.02 | 50.99 | 44.79 |
| Dividend Payout Ratio (CP) (%) | 36.11 | 58.94 | 63.07 | 46.24 | 41.19 |
| Earning Retention Ratio (%) | 60.80 | 34.91 | 28.98 | 49.01 | 55.21 |
| Cash Earning Retention Ratio (%) | 63.89 | 41.06 | 36.93 | 53.76 | 58.81 |
| Interest Coverage Ratio (X) | 97.76 | 92.77 | 137.04 | 230.27 | 205.78 |
| Interest Coverage Ratio (Post Tax) (X) | 67.41 | 60.91 | 86.31 | 166.65 | 148.31 |
| Enterprise Value (Cr.) | 3207.01 | 3284.31 | 1859.53 | 1441.35 | 932.75 |
| EV / Net Operating Revenue (X) | 7.97 | 9.90 | 6.67 | 5.82 | 3.75 |
| EV / EBITDA (X) | 15.56 | 20.68 | 13.55 | 13.50 | 7.34 |
| MarketCap / Net Operating Revenue (X) | 8.19 | 10.06 | 6.84 | 6.13 | 4.88 |
| Retention Ratios (%) | 60.79 | 34.90 | 28.97 | 49.00 | 55.20 |
| Price / BV (X) | 4.09 | 4.65 | 2.84 | 2.34 | 2.06 |
| Price / Net Operating Revenue (X) | 8.19 | 10.06 | 6.84 | 6.13 | 4.88 |
| EarningsYield | 0.04 | 0.03 | 0.04 | 0.04 | 0.07 |
After reviewing the key financial ratios for CARE Ratings Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 45.89. This value is within the healthy range. It has increased from 33.77 (Mar 24) to 45.89, marking an increase of 12.12.
- For Diluted EPS (Rs.), as of Mar 25, the value is 45.69. This value is within the healthy range. It has increased from 33.77 (Mar 24) to 45.69, marking an increase of 11.92.
- For Cash EPS (Rs.), as of Mar 25, the value is 50.69. This value is within the healthy range. It has increased from 37.87 (Mar 24) to 50.69, marking an increase of 12.82.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 269.37. It has increased from 240.23 (Mar 24) to 269.37, marking an increase of 29.14.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 269.37. It has increased from 240.23 (Mar 24) to 269.37, marking an increase of 29.14.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 134.41. It has increased from 111.11 (Mar 24) to 134.41, marking an increase of 23.30.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 68.85. This value is within the healthy range. It has increased from 53.20 (Mar 24) to 68.85, marking an increase of 15.65.
- For PBIT / Share (Rs.), as of Mar 25, the value is 64.94. This value is within the healthy range. It has increased from 49.69 (Mar 24) to 64.94, marking an increase of 15.25.
- For PBT / Share (Rs.), as of Mar 25, the value is 64.23. This value is within the healthy range. It has increased from 49.12 (Mar 24) to 64.23, marking an increase of 15.11.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 46.77. This value is within the healthy range. It has increased from 34.36 (Mar 24) to 46.77, marking an increase of 12.41.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 45.85. This value is within the healthy range. It has increased from 33.67 (Mar 24) to 45.85, marking an increase of 12.18.
- For PBDIT Margin (%), as of Mar 25, the value is 51.22. This value is within the healthy range. It has increased from 47.88 (Mar 24) to 51.22, marking an increase of 3.34.
- For PBIT Margin (%), as of Mar 25, the value is 48.31. This value exceeds the healthy maximum of 20. It has increased from 44.72 (Mar 24) to 48.31, marking an increase of 3.59.
- For PBT Margin (%), as of Mar 25, the value is 47.78. This value is within the healthy range. It has increased from 44.20 (Mar 24) to 47.78, marking an increase of 3.58.
- For Net Profit Margin (%), as of Mar 25, the value is 34.79. This value exceeds the healthy maximum of 10. It has increased from 30.92 (Mar 24) to 34.79, marking an increase of 3.87.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 34.11. This value exceeds the healthy maximum of 20. It has increased from 30.30 (Mar 24) to 34.11, marking an increase of 3.81.
- For Return on Networth / Equity (%), as of Mar 25, the value is 17.02. This value is within the healthy range. It has increased from 14.01 (Mar 24) to 17.02, marking an increase of 3.01.
- For Return on Capital Employeed (%), as of Mar 25, the value is 22.60. This value is within the healthy range. It has increased from 19.43 (Mar 24) to 22.60, marking an increase of 3.17.
- For Return On Assets (%), as of Mar 25, the value is 14.32. This value is within the healthy range. It has increased from 11.94 (Mar 24) to 14.32, marking an increase of 2.38.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.44. It has increased from 0.41 (Mar 24) to 0.44, marking an increase of 0.03.
- For Current Ratio (X), as of Mar 25, the value is 7.08. This value exceeds the healthy maximum of 3. It has decreased from 8.57 (Mar 24) to 7.08, marking a decrease of 1.49.
- For Quick Ratio (X), as of Mar 25, the value is 7.08. This value exceeds the healthy maximum of 2. It has decreased from 8.57 (Mar 24) to 7.08, marking a decrease of 1.49.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 39.20. This value is within the healthy range. It has decreased from 65.09 (Mar 24) to 39.20, marking a decrease of 25.89.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 36.11. This value is within the healthy range. It has decreased from 58.94 (Mar 24) to 36.11, marking a decrease of 22.83.
- For Earning Retention Ratio (%), as of Mar 25, the value is 60.80. This value is within the healthy range. It has increased from 34.91 (Mar 24) to 60.80, marking an increase of 25.89.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 63.89. This value is within the healthy range. It has increased from 41.06 (Mar 24) to 63.89, marking an increase of 22.83.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 97.76. This value is within the healthy range. It has increased from 92.77 (Mar 24) to 97.76, marking an increase of 4.99.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 67.41. This value is within the healthy range. It has increased from 60.91 (Mar 24) to 67.41, marking an increase of 6.50.
- For Enterprise Value (Cr.), as of Mar 25, the value is 3,207.01. It has decreased from 3,284.31 (Mar 24) to 3,207.01, marking a decrease of 77.30.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 7.97. This value exceeds the healthy maximum of 3. It has decreased from 9.90 (Mar 24) to 7.97, marking a decrease of 1.93.
- For EV / EBITDA (X), as of Mar 25, the value is 15.56. This value exceeds the healthy maximum of 15. It has decreased from 20.68 (Mar 24) to 15.56, marking a decrease of 5.12.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 8.19. This value exceeds the healthy maximum of 3. It has decreased from 10.06 (Mar 24) to 8.19, marking a decrease of 1.87.
- For Retention Ratios (%), as of Mar 25, the value is 60.79. This value is within the healthy range. It has increased from 34.90 (Mar 24) to 60.79, marking an increase of 25.89.
- For Price / BV (X), as of Mar 25, the value is 4.09. This value exceeds the healthy maximum of 3. It has decreased from 4.65 (Mar 24) to 4.09, marking a decrease of 0.56.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 8.19. This value exceeds the healthy maximum of 3. It has decreased from 10.06 (Mar 24) to 8.19, marking a decrease of 1.87.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.04, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in CARE Ratings Ltd:
- Net Profit Margin: 34.79%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 22.6% (Industry Average ROCE: 23.85%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 17.02% (Industry Average ROE: 17.4%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 67.41
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 7.08
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 30.2 (Industry average Stock P/E: 30.95)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 34.79%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Rating Services | 4th Floor, Godrej Coliseum, Somaiya Hospital Road, Mumbai Maharashtra 400022 | corp.comm@careedge.in http://www.careratings.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Najib Shah | Chairman(NonExe.&Ind.Director) |
| Mr. Mehul Harshadray Pandya | Managing Director & Group CEO |
| Mr. Sobhag Mal Jain | Non Exe.Non Ind.Director |
| Mr. V Chandrasekaran | Ind. Non-Executive Director |
| Ms. Sonal Desai | Ind. Non-Executive Director |
| Dr. M Mathisekaran | Ind. Non-Executive Director |
| Mr. Gurumoorthy Mahalingam | Ind. Non-Executive Director |
| Mr. Manoj Chugh | Ind. Non-Executive Director |
| Mr. Rajiv Bansal | Ind. Non-Executive Director |
| Ms. Indrani Banerjee | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of CARE Ratings Ltd?
CARE Ratings Ltd's intrinsic value (as of 30 November 2025) is 1267.11 which is 17.56% lower the current market price of 1,537.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 4,613 Cr. market cap, FY2025-2026 high/low of 1,965/1,052, reserves of ₹776 Cr, and liabilities of 958 Cr.
What is the Market Cap of CARE Ratings Ltd?
The Market Cap of CARE Ratings Ltd is 4,613 Cr..
What is the current Stock Price of CARE Ratings Ltd as on 30 November 2025?
The current stock price of CARE Ratings Ltd as on 30 November 2025 is 1,537.
What is the High / Low of CARE Ratings Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of CARE Ratings Ltd stocks is 1,965/1,052.
What is the Stock P/E of CARE Ratings Ltd?
The Stock P/E of CARE Ratings Ltd is 30.2.
What is the Book Value of CARE Ratings Ltd?
The Book Value of CARE Ratings Ltd is 288.
What is the Dividend Yield of CARE Ratings Ltd?
The Dividend Yield of CARE Ratings Ltd is 1.17 %.
What is the ROCE of CARE Ratings Ltd?
The ROCE of CARE Ratings Ltd is 24.6 %.
What is the ROE of CARE Ratings Ltd?
The ROE of CARE Ratings Ltd is 18.0 %.
What is the Face Value of CARE Ratings Ltd?
The Face Value of CARE Ratings Ltd is 10.0.